DEC 23, 2018 10:51 PM PST

Super-Drug for Pediatric Leukemia?

WRITTEN BY: Nouran Amin

In a final study published in Genes & Development, researchers at Northwestern University School of Medicine concluded their discoveries on two successful therapeutics that were seen to slow the progression of pediatric leukemia in model mice through the targeting of a key protein called MLL. "This opens up a new therapeutic approach not only for leukemia, which is so important for the many children who are diagnosed with this terrible cancer, but also for other types of cancers that plague the population," says first author and postdoctoral research fellow, Zibo Zhao.

Learn more about pediatric leukemia:

The mortality rate of childhood leukemia, a cancer affecting the blood and bone marrow, is very high with just a 30 percent survival rate. The study focused primarily on two of the most commonly found leukemia’s in children: acute myeloid leukemia (AML) and acute lymphocytic leukemia (ALL).

Credit: The Dana Farber Cancer Institute

"These white blood cells infiltrate many of the tissues and organs of the affected individuals and is a major cause of death in leukemia patients," says senior author of the study, Ali Shilatifard. "This is a monster cancer that we've been dealing with for many years in children."

The study identified the MLL stabilization process that therapeutically treats the cancer. Researchers are now hoping to combine these successful therapeutics for the ultimate ‘super-drug’ in targeting MLL effectively and decreasing the mortality rate among children diagnosed with pediatric leukemia. "I've been working on this translocation for more than two decades, and we're finally at the point where in five to 10 years, we can get a drug in kids that can be effective," Shilatifard said. "If we can bring that survival rate up to 85 percent, that's a major accomplishment."

Source: Genes & Development, Northwestern University

About the Author
  • Nouran is a scientist, educator, and life-long learner with a passion for making science more communicable. When not busy in the lab isolating blood macrophages, she enjoys writing on various STEM topics.
You May Also Like
MAY 03, 2021
Drug Discovery & Development
Low Dose Radiation May Improve Symptoms of Alzheimer's
MAY 03, 2021
Low Dose Radiation May Improve Symptoms of Alzheimer's
While high doses of radiation are known to be harmful, low doses may be able to help the body protect and repair. And no ...
MAY 06, 2021
Drug Discovery & Development
Tweaked Version of Ketamine Could Solve the Opioid Crisis
MAY 06, 2021
Tweaked Version of Ketamine Could Solve the Opioid Crisis
Medications that manage post-operative pain are some of the main entry points to opioid addiction and overdose in the US ...
MAY 13, 2021
Health & Medicine
New Peptide Allows Cannabis to Fight Pain With Fewer Side Effects
MAY 13, 2021
New Peptide Allows Cannabis to Fight Pain With Fewer Side Effects
THC-rich cannabis is well known to bring relief for some chronic pain sufferers. But the downside, off putting for many ...
MAY 15, 2021
Drug Discovery & Development
New Drug Blocks Critical Step in Malaria Life Cycle
MAY 15, 2021
New Drug Blocks Critical Step in Malaria Life Cycle
According to the World Health Organization (WHO), in 2019, there were approximately 229 million cases of malaria around ...
JUN 01, 2021
Immunology
Nanoparticles Designed to Enhance Seasonal Flu Vaccines
JUN 01, 2021
Nanoparticles Designed to Enhance Seasonal Flu Vaccines
Seasonal flu vaccines only work around 40 to 60 percent of the time, says the U.S. Centers for Disease Control and Preve ...
JUN 04, 2021
Drug Discovery & Development
Stem Cell Transplants May Treat Patients with Type 2 Diabetes
JUN 04, 2021
Stem Cell Transplants May Treat Patients with Type 2 Diabetes
Researchers at the Vinmec Research Institute of Stem Cell and Gene Technology in Hanoi, Vietnam have found that stem cel ...
Loading Comments...